- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07035639
- Original Trial
Exploring the Role of Baduanjin on Lumbar and Hip Mobility Index in Obese People Based on Infrared Thermography and Meridian Point Specificity
This study aimed to explore whether Baduanjin, a traditional fitness practice, can improve waist and hip mobility in obese individuals. Based on the TCM theory that "acupoints have unique effects," researchers hypothesized that Baduanjin might regulate muscle function by stimulating key abdominal and lumbar acupoints (such as Shenque and Guanyuan), thereby enhancing body flexibility.
The study recruited 60 overweight adults (BMI >28) from Beijing and Suzhou, randomly dividing them into two groups: one practiced Baduanjin 4 times a week for 8 weeks, while the other received no additional exercise. Using an infrared thermography device (similar to a "body temperature camera"), researchers measured temperature changes at abdominal and lumbar acupoints. They also evaluated waist mobility through forward bending, backward extension, and lateral flexion tests.
After 8 weeks, the Baduanjin group showed three significant improvements compared to the control group:
Enhanced flexibility: Waist and hip range of motion increased, such as reaching further during sit-and-reach tests.
Higher acupoint temperature: Skin temperature around Shenque, Guanyuan, and other acupoints rose, possibly indicating improved local blood circulation.
Better functional scores: Scores reflecting daily activity comfort and joint health significantly improved, while the control group showed no change.
In conclusion, Baduanjin may benefit obese individuals by "activating" abdominal and lumbar acupoints to optimize muscle function and mobility. Further research is needed to validate the underlying mechanisms.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Beijin
-
Beijin, Beijin, China, 100053
- China Academy of Chinese Medical Sciences Guang'anmen Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants with scores of 72 or above on the HEFESCM-36 scale of the China Association of Chinese Medicine, and meeting the following criteria:
Aged between 18 and 60 years; Able to independently participate in activities required for the physical study; Body mass index (BMI) >28; No musculoskeletal diseases or radiculopathy within one year prior to the trial; No receipt of physical therapy or surgical treatment within one year prior to the trial; Education level of high school or above; Proficient in using the WeChat check-in program; No mental illnesses and with normal learning and communication abilities; Agree to and voluntarily sign the informed consent form for trial participation.
Exclusion Criteria:
- Participants with confirmed specific etiologies, such as lumbar disc herniation, lumbar fracture, etc.; Individuals with 神经根 compression symptoms, such as sciatica, lumbar disc herniation, etc.; Cases with bacterial or aseptic inflammatory diseases, such as fever, rheumatoid arthritis, etc.; Subjects with other organ pathologies, such as kidney stones, typhlitis, appendicitis, etc.; Pregnant women; Individuals taking medications for mental disorders; Participants engaging in aerobic exercise >3 times/week or anaerobic exercise >4 times/week.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: The Baduanjin group
The Baduanjin group received training guided by national-level social sports instructors certified by the Institute of Sports Medicine, General Administration of Sport of China.
The intervention consisted of Baduanjin training 4 times per week for 8 consecutive weeks, with a total duration (including warm-up and breaks) of ≥30 minutes per session.
The training protocol included 16 minutes of Baduanjin exercise, a 2-minute break, and an additional 16 minutes of Baduanjin exercise.
|
The Baduanjin group received training guided by national-level social sports instructors certified by the Institute of Sports Medicine, General Administration of Sport of China.
The intervention consisted of Baduanjin training 4 times per week for 8 consecutive weeks, with a total duration (including warm-up and breaks) of ≥30 minutes per session.
The training protocol included 16 minutes of Baduanjin exercise, a 2-minute break, and an additional 16 minutes of Baduanjin exercise.
|
|
No Intervention: The blank control group
The blank control group received no exercise intervention and was advised to engage in no more than 3 sessions of aerobic exercise per week during the study.
Participants in the Baduanjin group were prohibited from undertaking any other form of exercise training throughout the research period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Infrared Thermography
Time Frame: 10min
|
Used for detecting human body surface temperature
|
10min
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018NO.03-2024NO.04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity and Overweight
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
PfizerRecruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal